NHC Share Price | National HealthCare Corp. Stock Analysis & Recommendation

Q: How big is National HealthCare Corp.?

Market Cap: As of Jun 18, National HealthCare Corp. has a market capitalization of 1,575.57 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, National HealthCare Corp. reported net sales of 1,363.30 million and a net profit of 108.13 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 980.16 million and total assets of 1,524.43 million.

Q: What does National HealthCare Corp. do?

Overview:National HealthCare Corporation (NHC) operates in the post-acute healthcare industry, providing skilled nursing facilities, assisted living, independent living, and homecare programs.Financial Snapshot:Most recent Net Sales: 372 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 32 Million (Quarterly Results - Mar 2025) Market cap: USD 1,575.57 Million (Micro Cap)Key Metrics:P/E: 16.00 Dividend Yield: 178.54% Debt Equity: -0.29 Return on Equity: 9.90% Price to Book: 1.57Contact Details:Address: 100 E Vine St, MURFREESBORO TN: 37130-3734 Tel: 1 615 8902020 Website: https://www.nhccare.com/

Q: Is National HealthCare Corp. overvalued or undervalued?

As of 5 August 2025, the valuation grade for National HealthCare Corp. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics. The P/E ratio stands at 16, while the industry average P/E is notably higher at approximately 18.51, indicating that National HealthCare is trading at a discount relative to its peers. Additionally, the EV to EBITDA ratio is 8.72, which is lower than the peer average of 9.12, further supporting the fair valuation stance.In comparison to its peers, Universal Health Services, Inc. has a P/E of 9.21, while Chemed Corp. is significantly more expensive with a P/E of 56.91. The PEG ratio for National HealthCare is 0.34, suggesting strong growth potential relative to its price. Over the past year, National HealthCare has underperformed the S&P 500, returning -3.46% compared to the index's 17.14%, which may indicate some market skepticism about its future growth prospects.

Q: Is National HealthCare Corp. technically bullish or bearish?

As of 3 October 2025, the technical trend for National HealthCare Corp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. Daily moving averages also indicate a bullish stance. While the Bollinger Bands show a mildly bullish trend on both weekly and monthly time frames, the KST is bullish weekly but mildly bearish monthly, suggesting some mixed signals. The Dow Theory indicates a mildly bullish trend on the weekly chart with no trend on the monthly. In terms of performance, the stock has underperformed the S&P 500 over the past week and year, but it has outperformed over the past month and three years. Overall, the current technical stance is bullish, with moderate strength driven by the MACD and moving averages.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

474.47 k

Shareholding (Dec 2025)

FII

3.62%

Held by 83 FIIs

DII

60.9%

Held by 37 DIIs

Promoter

0.08%

How big is National HealthCare Corp.?

22-Jun-2025

As of Jun 18, National HealthCare Corp. has a market capitalization of 1,575.57 million and reported net sales of 1,363.30 million with a net profit of 108.13 million over the latest four quarters.

View full answer

What does National HealthCare Corp. do?

22-Jun-2025

National HealthCare Corporation (NHC) operates in the post-acute healthcare sector, offering skilled nursing, assisted living, independent living, and homecare services. As of March 2025, it reported net sales of $372 million and a net profit of $32 million, with a market cap of approximately $1.58 billion.

View full answer

Who are in the management team of National HealthCare Corp.?

22-Jun-2025

As of March 2022, the management team of National HealthCare Corp. includes Non-Executive Chairman Mr. Robert Adams, CEO Dr. Stephen Flatt, Directors Mr. W. Andrew Adams, Dr. J. Paul Abernathy, Mr. Ernest Burgess, and Independent Director Mr. Emil Hassan. They oversee the company's operations and strategic direction.

View full answer

Is National HealthCare Corp. overvalued or undervalued?

20-Sep-2025

As of August 5, 2025, National HealthCare Corp. is fairly valued with a P/E ratio of 16, lower than the industry average of 18.51, and despite strong growth potential indicated by a PEG ratio of 0.34, it has underperformed the S&P 500 with a return of -3.46% over the past year.

View full answer

Is National HealthCare Corp. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, National HealthCare Corp. shows a bullish technical trend supported by positive MACD and moving averages, despite mixed signals from Bollinger Bands and KST, while underperforming the S&P 500 recently but outperforming it over the past month and three years.

View full answer

Compare National HealthCare Corp. with Similar Stocks

Premier, Inc.Select Medical Holdings Corp.Surgery Partners, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

USD 2,564 Million (Small Cap)

P/E

26.00

Industry P/E

Dividend Yield

1.52%

Debt Equity

-0.33

Return on Equity

9.30%

Price to Book

2.43

Revenue and Profits:

Net Sales:

385 Million

(Quarterly Results - Dec 2025)

Net Profit:

25 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

12.1%

6 Months

33.38%

1 Year

70.71%

2 Years

73.09%

3 Years

186.35%

4 Years

126.32%

5 Years

100.49%

National HealthCare Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.32%

EBIT Growth (5y)

-52.02%

EBIT to Interest (avg)

54.58

Debt to EBITDA (avg)

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.29

Tax Ratio

25.13%

Dividend Payout Ratio

37.03%

Pledged Shares

Institutional Holding

67.01%

ROCE (avg)

13.53%

ROE (avg)

7.00%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.43

EV to EBIT

-123.36

EV to EBITDA

83.24

EV to Capital Employed

3.14

EV to Sales

1.48

PEG Ratio

Dividend Yield

1.52%

ROCE (Latest)

-2.55%

ROE (Latest)

9.30%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Bullish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 56 Schemes (35.34%)

Foreign Institutions

Held by 83 Foreign Institutions (3.62%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.05% vs 2.06% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -38.54% vs 70.12% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "384.80",
          "val2": "380.80",
          "chgp": "1.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "38.80",
          "val2": "-76.00",
          "chgp": "151.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "1.50",
          "chgp": "-46.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.70",
          "val2": "1.80",
          "chgp": "-5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "25.20",
          "val2": "41.00",
          "chgp": "-38.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "70.10%",
          "val2": "-229.00%",
          "chgp": "29.91%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.70% vs 12.23% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 20.08% vs 56.36% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,510.50",
          "val2": "1,251.50",
          "chgp": "20.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "188.40",
          "val2": "106.90",
          "chgp": "76.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.40",
          "val2": "4.10",
          "chgp": "56.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.20",
          "val2": "12.70",
          "chgp": "-43.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "122.60",
          "val2": "102.10",
          "chgp": "20.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "95.00%",
          "val2": "51.90%",
          "chgp": "4.31%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

384.80

380.80

1.05%

Operating Profit (PBDIT) excl Other Income

38.80

-76.00

151.05%

Interest

0.80

1.50

-46.67%

Exceptional Items

1.70

1.80

-5.56%

Consolidate Net Profit

25.20

41.00

-38.54%

Operating Profit Margin (Excl OI)

70.10%

-229.00%

29.91%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 1.05% vs 2.06% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -38.54% vs 70.12% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,510.50

1,251.50

20.70%

Operating Profit (PBDIT) excl Other Income

188.40

106.90

76.24%

Interest

6.40

4.10

56.10%

Exceptional Items

7.20

12.70

-43.31%

Consolidate Net Profit

122.60

102.10

20.08%

Operating Profit Margin (Excl OI)

95.00%

51.90%

4.31%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 20.70% vs 12.23% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 20.08% vs 56.36% in Dec 2024

All Annual Results

Company CV

About National HealthCare Corp.

National HealthCare Corp.

Hospital

National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home healthcare services. It has interest in a hospice care business that services NHC owned healthcare centers and others. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. As of December 31, 2016, it owned the real estate of 13 healthcare properties and leased these properties to third-party operators. As of December 31, 2016, it operated in 10 states, and its owned and leased properties are located in various parts of the United States.

Company Coordinates

Company Details

100 E Vine St , MURFREESBORO TN : 37130-3734

Tel: 1 615 8902020

https://www.nhccare.com/

Registrar Details